Items where authors include "Perry, E."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. orcid.org/0009-0004-3067-9939 et al. (202 more authors) (2025) Two-neutrino double electron capture of 124Xe in the first LUX-ZEPLIN exposure. Journal of Physics G: Nuclear and Particle Physics, 52 (1). 015103. ISSN 0954-3899

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (200 more authors) (2024) Constraints on covariant dark-matter–nucleon effective field theory interactions from the first science run of the LUX-ZEPLIN experiment. Physical Review Letters, 133. 221801. ISSN 0031-9007

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (213 more authors) (2024) The data acquisition system of the LZ dark matter detector: FADR. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 1068. 169712. ISSN 0168-9002

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (201 more authors) (2024) Probing the scalar WIMP-pion coupling with the first LUX-ZEPLIN data. Communications Physics, 7 (1). 292. ISSN 2399-3650

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (201 more authors) (2024) The design, implementation, and performance of the LZ calibration systems. Journal of Instrumentation, 19. P08027.

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (206 more authors) (2024) New constraints on ultraheavy dark matter from the LZ experiment. Physical Review D, 109. 112010. ISSN 2470-0010

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (198 more authors) (2024) First constraints on WIMP-nucleon effective field theory couplings in an extended energy region from LUX-ZEPLIN. Physical Review D, 109 (9). 092003. ISSN 2470-0010

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Aalbers, J., Akerib, D.S., Al Musalhi, A.K. et al. (199 more authors) (2023) Search for new physics in low-energy electron recoils from the first LZ exposure. Physical Review D, 108. 072006. ISSN 2470-0010

Aalbers, J., Akerib, D.S., Akerlof, C.W. et al. (345 more authors) (2023) First dark matter search results from the LUX-ZEPLIN (LZ) experiment. Physical Review Letters, 131. 041002. ISSN 0031-9007

Aalbers, J., Akerib, D.S., Musalhi, A.K.A. et al. (200 more authors) (2023) Background determination for the LUX-ZEPLIN dark matter experiment. Physical Review D, 108. 012010. ISSN 2470-0010

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736